secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVANTA INC (NOVT)
CIK:        0001076930
Form:       8-K
Filed at:   2026-07-27T12:15:15+00:00
Accession:  0001193125-26-316947
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 2.01, 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novanta completes $1.2B acquisition of Riverpoint Medical; expects $0.18-$0.25 adjusted EPS accretion in 2027
--------------------------------------------------------------------------------

- Acquired Riverpoint Medical for ~$1.2B cash at closing; additional $250M milestone payment due by Jan 8, 2027.
- Funded with $616M in borrowings under credit facilities; total consolidated debt now $854.7M.
- Deal expected to double recurring medical consumables revenue to ~$300M and push medical end-market to 60% of total revenue.
- Expects $0.18-$0.25 adjusted EPS accretion in 2027, high single-digit ROIC by year three, and immediate accretion to margins.
- Riverpoint is a category leader in minimally invasive surgical consumables for sports medicine, trauma, and cardiovascular applications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1076930/000119312526316947/0001193125-26-316947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1076930/000119312526316947/novt-20260722.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-316947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer